Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse

Shock

Volumn 6, Issue 3, 1996, Pages 171-176

  Burress Welborn III, M ^a   Douglas, Wade G ^a   Abouhamze, Zaher ^a   Auffenburg, Troy ^a   Abouhamze, Amer S ^a   Baumhofer, Julie ^a   Seeger, James M ^a   Pruitt, Jeffrey H ^a   Edwards, Paul D ^a   Chizzonite, Richard ^b   Martin, David ^a   Moldawer, Lyle L ^c,d   Harward, Timothy R S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 6; PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CAPILLARY PERMEABILITY; FEMALE; INJURY; LIVER; LUNG; MALE; METABOLISM; METHODOLOGY; MOUSE; REPERFUSION INJURY; TIME; VASCULAR SURGERY; VASCULARIZATION;

ANIMALS; AORTA, ABDOMINAL; ASPARTATE AMINOTRANSFERASES; CAPILLARY PERMEABILITY; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; REPERFUSION INJURY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR SURGICAL PROCEDURES;

EID: 0030225720     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199609000-00003     Document Type: Article

References (27)

1. Golden MA, Donaldson MC, Whittemore AD, Mannick JA: Evolving experience with thoracoabdominal aortic aneurysm repair at a single institution. J Vasc Surg 13:792-796, 1991.
2. Schepens MA, Defauw JJ, Hamerlijnck RP, De Geest R, Vermeulen FE: Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping: Risk factors and late results. J Thorac Cardiovasc Surg 107:134-142, 1994.
3. Money SR, Rice K, Crockett D, Becker M, Abdoh A, Wisselink W, Kazmier F, Hollier L: Risk of respiratory failure after repair of thoracoabdominal aortic aneurysms. Am J Surg 168:152-155, 1994.
4. McCurry KR, Campbell DA Jr, Scales WE, Warren JS, Remick DG: Tumor necrosis factor, interleukin 6, and the acute phase response following hepatic ischemia/reperfusion. J Surg Res 55:49-54, 1993.
5. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Stricter RM, Campbell DAJ: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936-1943, 1990.
6. Colletti LM, Burtch GD, Remick DG, et al.: The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49:268-272, 1990.
7. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI: Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 212:694-700, 1990.
8. Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 218:444-453, 1993.
9. Gershenwald JE, Fong YM, Fahey TJ, et al.: Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 87:4966-4970, 1990.
10. Oldenburg HS, Rogy MA, Lazarus DD, et al.: Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol 23:1889-1894, 1993.
11. Espat NJ, Cendan JC, Beierle EA, et al.: PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J Surg Res 59:153-158, 1995.
12. McIntyre KW, Stepan GJ, Kolinsky KD, et al.: Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173:931-939, 1991.
13. Russell DA, Tucker KK, Chinookoswong N, Thompson RC, Kohno T: Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: Improved survival and organ function. J Infect Dis 171: 1528-1538, 1995.
14. Solorzano CC, Pruitt JH, Ksontini R, et al.: Involvement of 26 kD cell-associated TNF in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J Immunol 1996. In press.
15. Espevik T, Nissen Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
16. Welboum R, Goldman G, O'Riordain M, et al.: Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol 70:2645-2649, 1991.
17. Koike K, Moore EE, Moore FA, Read RA, Carl VS, Banerjee A: Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med 22:1438-1444, 1994.
18. Terada LS, Dormish JJ, Shanley PF, Leff JA, Anderson BO, Repine JE: Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 263:L394-401, 1992.
19. Dupont GP, Huecksteadt TP, Marshall BC, Ryan US, Michael JR, Hoidal JR: Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest 89:197-202, 1992.
20. Royall JA, Gwin PD, Parks DA, Freeman BA: Responses of vascular endothelial oxidant metabolism to lipopolysaccharide and tumor necrosis factor-alpha. Arch Biochem Biophys 294:686-694, 1992.
21. Robson AK, Currie IC, Poskitt KR, Scott DJ, Baird RN, Horrocks M: Abdominal aortic aneurysm repair in the over eighties. Br J Surg 76: 1018-1020, 1989.
22. Thompson JE, Hollier LH, Patman RD, Persson AV: Surgical management of abdominal aortic aneurysms: Factors influencing mortality and morbidity - a 20-year experience. Ann Surg 181:654-661, 1975.
23. Cox GS, O'Hara PJ, Hertzer NR, Piedmonte MR, Krajewski LP, Beven EG: Thoracoabdominal aneurysm repair: A representative experience. J Vasc Surg 15:780-787, 1992.
24. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA: Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 143:453-463, 1993.
25. Huber TS, Harward TRS, Flynn TC, Albright JL, Seeger JM: Operative mortality rates after elective infrarenal aortic reconstructions. J Vasc Surg 22:287-294, 1995.
26. Liu P, Vonderfecht SL, Fisher MA, McGuire GM, Jaeschke H: Priming of phagocytes for reactive oxygen production during hepatic ischemia-reperfusion potentiates the susceptibility for endotoxin-induced liver injury. Circ Shock 43:9-17, 1994.
27. Harward TR, Brooks DL, Flynn TC, Seeger JM: Multiple organ dysfunction after mesenteric artery revascularization. J Vasc Surg 18:459-467, 1993.